WIA
TELO icon

World Investment Advisors’s Telomir Pharmaceuticals TELO Stock Holding History

World Investment Advisors’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.1K Hold
37,037
– – ﹤0.01% 1512
2026
Q1 		$48.1K Buy
37,037
+1,600
+5% +$2.04K ﹤0.01% 1552
2025
Q4 		$47.1K Buy
+35,437
New +$51.1K ﹤0.01% 1453

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

World Investment Advisors's TELO Position: Q2 2026 in Review

World Investment Advisors held its Telomir Pharmaceuticals (TELO) position steady in Q2 2026 at 37,037 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

World Investment Advisors first reported a position in TELO in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • World Investment Advisors held 37,037 shares of Telomir Pharmaceuticals worth $48.1K as of Q2 2026.
  • World Investment Advisors left its Telomir Pharmaceuticals share count unchanged in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1512 holding.
  • World Investment Advisors first reported a position in Telomir Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.